Our scientists support your program with their expertise to mitigate any acute and potentially life-threatening risks your compound may have. Streamline your preclinical phase by integrating safety pharmacology assessments into your toxicology studies and IND programs.
Why Charles River for your safety pharmacology studies?
- You'll benefit from a full suite of studies, evaluating in vitro and in vivo safety to meet the ICH guidance, as well as mechanistic studies to de-risk your compound.
- Our scientists interact with industry experts, academic institutions, and regulatory agencies innovating safety pharmacology assays and the tools needed to further the translation of your preclinical data to clinical outcomes.
- You can make quick program decisions with real-time access to data from Apollo™.
- You will receive personalized support for your program from our team of scientific advisors.
No matter how difficult the question or rare the compound, Charles River is always on the top of their game. This company continues to develop new skills to stay competitive and their scientific approaches are cutting edge. I know I can always count on them for their support, which is why I continue to come back time and time again.”
Associate Director of Toxicology, Pharmaceutical Company